|
|
Other links at Articles > Cardiology |
| 1. |
FDA Approvals: Diovan, Renvela, Humate-P
|
|
|
The FDA has approved an expanded indication for valsartan tablets, sevelamer carbonate tablets, and new storage conditions for factor VIII/von Willebrand factor complex intravenous injection. Medscape Medical News
|
| 3. |
Meta-Analysis Shows That Statins Reduce the Incidence and Recurrence of AF
|
|
|
French investigators showed that the use of statins was significantly associated with a decreased risk of incidence or recurrence of atrial fibrillation in patients in sinus rhythm with a history of previous AF, those undergoing cardiac surgery, or those prescribed the drugs after an acute coronary syndrome. The findings, say investigators, point to the benefit of statins beyond their ability to lower LDL cholesterol. Heartwire
|
| 4. |
Echo Contrast Agents "Safe"; FDA Should Reconsider Warnings
|
|
|
A new analysis has shown that the benefits of using ultrasound contrast agents outweigh the risks. Most important, withholding the use of such agents in patients who need them can be detrimental, says the lead investigator. Reporting her findings last week, she called on the FDA to reconsider the warnings it has placed on these products. Heartwire
|
|
|
